ES2529552T3 - Solución de tratamiento para el tratamiento de heridas, especialmente para el tratamiento de heridas líquido - Google Patents

Solución de tratamiento para el tratamiento de heridas, especialmente para el tratamiento de heridas líquido Download PDF

Info

Publication number
ES2529552T3
ES2529552T3 ES10710992.8T ES10710992T ES2529552T3 ES 2529552 T3 ES2529552 T3 ES 2529552T3 ES 10710992 T ES10710992 T ES 10710992T ES 2529552 T3 ES2529552 T3 ES 2529552T3
Authority
ES
Spain
Prior art keywords
treatment
wounds
solution
liquid
proportion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10710992.8T
Other languages
English (en)
Inventor
Thomas Riesinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAWA HEILMITTEL GmbH
Original Assignee
NAWA HEILMITTEL GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42115873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2529552(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by NAWA HEILMITTEL GmbH filed Critical NAWA HEILMITTEL GmbH
Application granted granted Critical
Publication of ES2529552T3 publication Critical patent/ES2529552T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Solución de tratamiento para el tratamiento de heridas líquido para heridas agudas y crónicas, constituida por una solución acuosa que contiene al menos cinc, hierro y ácido, en la cual por cada litro de solución la proporción de cinc es 15- 45 mg, la proporción de hierro 10-30 mg y la proporción de ácido se elige de tal modo que el valor del pH de la solución de tratamiento sea 2,75 a 3,5, caracterizada porque la solución contiene adicionalmente el tensioactivo cocamidopropil betaína, así como un componente antiséptico, siendo la proporción de cocamidopropil betaína 1000 a 6000 mg y la proporción del componente antiséptico 100 a 1000 mg.

Description

imagen1
imagen2

Claims (1)

  1. imagen1
ES10710992.8T 2009-02-13 2010-02-05 Solución de tratamiento para el tratamiento de heridas, especialmente para el tratamiento de heridas líquido Active ES2529552T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102009008919A DE102009008919A1 (de) 2009-02-13 2009-02-13 Behandlungslösung für die Behandlung von Wunden, insbesondere für die liquide Wundbehandlung
DE102009008919 2009-02-13
PCT/DE2010/000129 WO2010091661A1 (de) 2009-02-13 2010-02-05 Behandlungslösung für die behandlung von wunden, insbesondere für die liquide wundbehandlung

Publications (1)

Publication Number Publication Date
ES2529552T3 true ES2529552T3 (es) 2015-02-23

Family

ID=42115873

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10710992.8T Active ES2529552T3 (es) 2009-02-13 2010-02-05 Solución de tratamiento para el tratamiento de heridas, especialmente para el tratamiento de heridas líquido

Country Status (5)

Country Link
US (1) US8846109B2 (es)
EP (1) EP2395989B1 (es)
DE (1) DE102009008919A1 (es)
ES (1) ES2529552T3 (es)
WO (1) WO2010091661A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012007212A1 (de) 2012-04-11 2013-10-17 Merz Pharma Gmbh & Co. Kgaa Zubereitung zur topischen Anwendung auf Schleimhäuten mit Polyhexanid als Wirkstoff
DE202014100305U1 (de) * 2013-12-23 2015-04-20 Nawa-Heilmittel Gmbh Transparentes Gel
DE102020107665A1 (de) 2020-03-19 2021-09-23 Nawa-Heilmittel Gmbh Verwendung einer wässrigen Lösung zur keimreduzierenden Reinigung von Oberflächen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150081A (en) * 1962-08-14 1964-09-22 Du Pont Method of preventing precipitation of iron compounds from an aqueous solution
DE3537627C2 (de) 1984-11-03 1995-01-26 Infectless S A Desinfektionsmittel und seine Verwendung
DE3929411A1 (de) * 1988-09-22 1990-03-29 Siegfried Natterer Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung
US5244666A (en) * 1992-02-04 1993-09-14 Consolidated Chemical, Inc. Presurgical skin scrub and disinfectant
AU1969500A (en) * 1998-12-05 2000-06-26 Fresenius Kabi Deutschland Gmbh Use of poly (hexamethylene) biguanide for producing an agent for promoting the healing of uninfected wounds
CA2362613C (en) * 1999-12-13 2010-09-28 Ethicon, Inc. Stabilized antimicrobial systems and methods of making the same
DE10139400A1 (de) 2001-01-18 2002-07-25 Nawa Heilmittel Gmbh Behandlungslösung für die postoperative Wundversorgung sowie Verbandmaterial zur Verwendung mit dieser Behandlungslösung
DE10132817A1 (de) 2001-07-06 2003-01-30 Prontomed Gmbh Wundbehandlungsmittel
US20040076686A1 (en) * 2001-08-10 2004-04-22 Thomas Riesinger Treatment solution used for caring wounds in addition to dressing material for use with said treatment solution
DE102007030931A1 (de) 2007-07-03 2009-01-08 Birgit Riesinger Zusammensetzung, enthaltend mindestens einen nutritiven, mindestens einen desinfizierenden bzw. dekontaminierenden und/oder mindestens einen Proteasen hemmend wirkenden Wirkstoff und/oder Wirkstoffkomplex
US20100233289A1 (en) * 2009-03-12 2010-09-16 Dennis Smithyman Antimicrobial acid formulation

Also Published As

Publication number Publication date
DE102009008919A1 (de) 2010-08-26
US20110318428A1 (en) 2011-12-29
EP2395989A1 (de) 2011-12-21
EP2395989B1 (de) 2014-12-24
WO2010091661A1 (de) 2010-08-19
US8846109B2 (en) 2014-09-30

Similar Documents

Publication Publication Date Title
ES2493316T3 (es) GLYX-13 para uso en un método para tratar depresión que no responde al tratamiento
MX352949B (es) Composicion farmaceutica.
ECSP11010803A (es) Compuestos de cobre nanoparticulados
PE20142350A1 (es) Composicion para el tratamiento de aguas y metodos de uso
HK1212207A1 (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
EP4335507A3 (en) Combination therapy
EP3412668A3 (en) A selective inhibitor of phosphatidylinositol 3-kinase-gamma
NI201100144A (es) Composición farmacéutica sólida que contiene amlopidina y losartán, así como el proceso para producir la misma.
AR081541A1 (es) Composicion detergente
UY32644A (es) Compuesto anticancerígeno y composición farmacéutica que lo contiene
CA2862669A1 (en) Application of fluorescent dyes to trace and quantify chemical dosage in industrial wastewater
ES2509966T1 (es) Composiciones que tienen concentraciones incrementadas de carboximetilcelulosa
UY31751A (es) Composiciones que tienen actividad biocida para preparaciones acuosas
WO2011089234A8 (en) Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
WO2015061632A3 (en) Antimicrobial compositions and articles
BR112015014787A2 (pt) mitigação de corrosão e incrustação usando aditivos baseados em componentes sem fósforo
EP2283727A3 (en) Treatment of ornamental plants
MX2015016057A (es) Solucion estabilizada de acido hipocloroso y uso de la misma.
ES2529552T3 (es) Solución de tratamiento para el tratamiento de heridas, especialmente para el tratamiento de heridas líquido
FI2034956T4 (fi) Matalan viskositeetin omaavia glykosaminoglykaaneja käsittäviä koostumuksia ja mainitun koostumuksen käyttö kroonisen kystiitin terapiassa
AR097596A1 (es) Proceso para preparar celulosa
MX2015014575A (es) Barra de jabon que tiene actividad antibacteriana mejorada.
WO2015038689A3 (en) Cationic antiseptic compositions
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
AR097069A1 (es) Fluidos de tratamiento que contienen un agente quelante perfluorado y métodos para su uso